C.R. Bard
LEI 549300XS4HD3R8MDYK78
Upgrade to Premium features
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get access-
Full access to the largest bond database
Bond parameters,
prospectuses -
Seamless
Data exportAnalyze the data in the most efficient way
-
Bond pricing
Current & historical quotes from 400+ stock exchanges & OTC market
-
Smart risk assessment
Credit ratings, financial reports
Trading Schedule Issuer map
Quotes
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Profile
|
C. R. Bard products fall into four general therapeutic categories: vascular, oncology, urology, and surgical specialties. Among other things, the company makes stents, catheters, and guidewires used in angioplasties and other vascular procedures; catheters for delivering chemotherapy treatments; and urology catheters and products used to treat urinary incontinence. Its line of specialty surgical tools, made by subsidiary Davol, includes devices used in laparoscopic and orthopedic procedures and for hernia repair
|
General information
-
Organization nameBard (C.R.), Inc.
-
Organization statusOperating organization
-
Address730 Central Avenue Murray Hill, USA, 07974
-
Site
IFRS/US GAAP reports
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Stocks
General information
-
Organization nameBard (C.R.), Inc.
-
Organization statusOperating organization
-
Address730 Central Avenue Murray Hill, USA, 07974
-
Site
Codes
-
LEI549300XS4HD3R8MDYK78
-
SIC3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
-
NACE*** ***
-
NAICS*** ***
-
CIK0000009892









